印度新德里一家慢性病医疗保健机构的医护人员和其他工作人员在接种疫苗后突破性感染 COVID19。
Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India.
机构信息
Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Chirag Enclave, Nehru Place, New Delhi, India.
Centre of Nutrition & Metabolic Research (C-NET), National Diabetes, Obesity and Cholesterol Foundation (N-DOC), SDA, New Delhi, India; Diabetes Foundation (India), SDA, New Delhi, India; Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Chirag Enclave, Nehru Place, New Delhi, India.
出版信息
Diabetes Metab Syndr. 2021 May-Jun;15(3):1007-1008. doi: 10.1016/j.dsx.2021.05.001. Epub 2021 May 3.
BACKGROUND AND AIMS
Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility.
METHODS
We reviewed rigorously maintained data of vaccinations, health status, symptoms of COVID19 & RT-PCR testing of all staff (doctors, nurses, paramedical workers, and other staff) in our health care facility from January 16, 2021 till date.
RESULTS
Out of 123 employees, 113 were vaccinated (Covaxin, 28, Covishield, 85). Second dose was completed in 107 (94.7%) and first dose in 6 persons (5.3%). Symptomatic COVD19 infections occurred in 19 persons (16.9%) post any dose of vaccine. Symptomatic breakthrough infections > 14 days after second dose occurred in 15 persons (13.3%). Except one (required hospitalization), all 14 had mild COVID19 disease.
CONCLUSIONS
We report mild symptomatic breakthrough infections as seen in our health care facility. Research in breakthrough infections in India should be extended to other institutions and community to obtain larger data.
背景和目的
印度现在向所有成年人开放 COVID19 疫苗接种。然而，COVID19 感染的传播仍未减弱。我们旨在确定在一家专注于慢性疾病和糖尿病的医疗保健机构中接种疫苗后突破性 COVID19 感染的数量。
方法
我们严格审查了我们医疗保健设施中所有员工（医生、护士、辅助医疗工作者和其他员工）自 2021 年 1 月 16 日以来的疫苗接种、健康状况、COVID19 症状和 RT-PCR 检测的数据。
结果
在 123 名员工中，有 113 人接种了疫苗（Covaxin，28 人；Covishield，85 人）。107 人（94.7%）完成了第二剂，6 人（5.3%）完成了第一剂。在接种任何一剂疫苗后，有 19 人（16.9%）出现了有症状的 COVD19 感染。在第二剂后 14 天以上出现有症状的突破性感染的有 15 人（13.3%）。除 1 人（需要住院治疗）外，所有 14 人都患有轻度 COVID19 疾病。
结论
我们报告了在我们的医疗保健机构中看到的轻度有症状的突破性感染。应将印度突破性感染的研究扩展到其他机构和社区，以获得更大的数据。
Zotero 插件